Clinical Trial Update: RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

A Phase 3 randomized, blinded, two-arm efficacy study evaluating IP vs placebo in chronic knee osteoarthritis pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Arthritis
• Osteoarthritis of the Knee

Drugs mentioned

• IP

Snippet

Sponsor: Overseas Pharmaceuticals, Ltd. | Conditions: Degenerative Arthritis | Phase 3 | Status: UNKNOWN